Supernus Pharmaceuticals | SUPN - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Abbott USD 1.74B 2.94M 2026-03
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Aurora Cannabis CAD 63.31M 4.36M 2026-06
Bristol-Myers Squibb USD 2.04B 7M 2026-06
Canopy Growth CAD 422.07M 53.78M 2026-03
Cara Therapeutics USD 9.38M 2.01K 2026-03
Corcept Therapeutics USD 109.36M 1.44M 2026-09
Eisai JPY 282.46M 0 2026-09
Eli Lilly USD 943.5M 3.33M 2026-03
Novo Nordisk DKK 4.43B 13.25M 2026-06
Pacira USD 39.9M 75K 2026-09
Perrigo USD 138.8M 700K 2026-09
Pfizer USD 5.7B 1000K 2026-09
Supernus Pharmaceuticals USD 58.16M 124K 2026-06
United Therapeutics USD 42.38M 295K 2026-09
Xeris Pharmaceuticals USD 173.59M 1.03M 2026-06